Bioinformatics is an interdisciplinary science that integrates computer science, biology, chemistry, mathematics, and statistics to analyze complex biological data. In Europe, bioinformatics has become a critical enabler for understanding biomolecular structures, gene expression patterns, protein interactions, and disease mechanisms.
The field supports a wide range of applications, including genomics, proteomics, transcriptomics, metabolomics, disease gene identification, metabolic pathway analysis, and drug discovery. The rapid advancement of next-generation sequencing (NGS) technologies has significantly increased the volume of biological data generated, intensifying the need for robust bioinformatics tools across healthcare and research environments.
According to BIS Research, the Europe bioinformatics market was valued at $4.27 billion in 2024 and is projected to reach $15.42 billion by 2035, growing at a CAGR of 12.42% during the forecast period 2025–2035, highlighting the expanding role of bioinformatics in European healthcare, genetics, and life sciences research.
Download the full TOC and book a preview
Key Drivers:?
• Rapid increase in genomic, proteomic, and metabolomic datasets requiring advanced computational analysis
• Rising adoption of precision medicine and personalized therapies across European healthcare systems
• Strong government and EU-led initiatives promoting genomics, biotechnology, and life sciences research
• Expansion of biotechnology and pharmaceutical R&D activities in key European markets
• Technological advancements in artificial intelligence, machine learning, and data analytics
• Growing need to reduce drug discovery timelines and improve research efficiency
According to a Principal Analyst at BIS Research:
“The Europe bioinformatics market is poised for robust expansion, driven by the rapid growth of genomic data, increasing precision medicine initiatives, and sustained investments in life sciences research. Advances in AI, machine learning, and cloud computing will continue to enhance analytical capabilities and scalability. Despite challenges related to workforce availability and data security, bioinformatics will remain a foundational pillar of Europe’s healthcare, genomics, and biotechnology ecosystem.”
The Europe bioinformatics market is expected to grow from $4.27 billion in 2024 to $15.42 billion by 2035, registering a CAGR of 12.42% during the forecast period 2025–2035.
Key companies operating in the Europe bioinformatics market include Eurofins Scientific, Fios Genomics Ltd., QIAGEN, and SOPHiA GENETICS.
Genomics and proteomics currently dominate market demand, while transcriptomics and metabolomics are gaining traction due to their growing importance in precision medicine and drug development.
BIS Research provides expert-led market intelligence, detailed segmentation, and strategic advisory services across healthcare, biotechnology, and life sciences domains.
[Contact Analyst]
[Download the complete TOC]
